Related Experiment Video
Updated: May 15, 2026

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
Published on: May 7, 2020
Expanding the spectrum of MERS type 2 lesions, a particular form of encephalitis
Anneleen Notebaert1, Jef Willems, Line Coucke
1Department of Pediatric Neurology, Ghent University Hospital, Ghent, Belgium. anneleen.notebaert@gmail.com
Abstract:
We report on a 13-year-old boy who presented with signs suggestive of encephalitis and in whom magnetic resonance imaging revealed lesions in the genu and splenium of the corpus callosum and symmetrical lesions bilaterally in the center semiovale. This clinical-radiologic entity was previously reported in the literature and was given the acronym MERS type 2 (mild encephalitis with reversible splenial) lesion. The clinical, radiologic, and biochemical characteristics of the patient with MERS type 2 lesions presented in this article show some differences with those in previously reported patients. His clinical recovery was particularly slow, cerebrospinal fluid was abnormal, and on magnetic resonance imaging the typical time course of MERS type 2 lesions resolving through a phase of solitary lesions in the splenium of the corpus callosum, the so-called type 1 lesions, was not seen. He is also the first patient in whom mycoplasma pneumoniae was found to be associated with MERS type 2 lesions. These findings further expand the spectrum of MERS type 2 lesions. The question raises whether the MERS type 2 lesion represents a new type of encephalitis or a particular radiologically recognizable subtype of postinfectious encephalitis. In the article, previously reported patients with MERS type 2 lesions are reviewed.
Insights
This study details a unique case of mild encephalitis with reversible splenial (MERS) type 2 lesions in a 13-year-old boy, noting atypical recovery and the first association with Mycoplasma pneumoniae.
Area of Science:
- Neurology
- Infectious Diseases
- Radiology
Background:
- Mild encephalitis with reversible splenial (MERS) type 2 lesions are a recognized clinical-radiologic entity.
- Previous cases have established typical clinical, radiological, and biochemical profiles.
Observation:
- A 13-year-old boy presented with encephalitis symptoms and characteristic MERS type 2 lesions on MRI.
- This patient exhibited slower clinical recovery, abnormal cerebrospinal fluid, and atypical MRI lesion resolution.
- Mycoplasma pneumoniae was identified as a potential associated pathogen, a novel finding for MERS type 2.
Findings:
- The patient's presentation diverged from previously reported MERS type 2 lesion cases.
- The typical resolution pattern of MERS type 2 lesions was not observed.
- This case represents the first documented link between Mycoplasma pneumoniae and MERS type 2 lesions.
Implications:
- These findings broaden the understanding of MERS type 2 lesions.
- The case prompts further investigation into whether MERS type 2 represents a distinct encephalitis or a post-infectious subtype.
- Further research is needed to elucidate the full spectrum and etiology of MERS type 2 lesions.
More Related Videos
05:33A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
Published on: June 23, 2022
06:57Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Viral Meningitis
Bacterial Meningitis II: Pathophysiology
Arboviral Encephalitis
Bacterial Meningitis I: Introduction